Kim Gi-Cheon, Lee Choong-Gu, Verma Ravi, Rudra Dipayan, Kim Taemook, Kang Keunsoo, Nam Jong Hee, Kim Young, Im Sin-Hyeog, Kwon Ho-Keun
Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, South Korea.
Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, South Korea.
Front Oncol. 2020 May 14;10:642. doi: 10.3389/fonc.2020.00642. eCollection 2020.
has shown dichotomous roles as an oncogene and a tumor suppressor gene in diverse cancers, but its functionality in breast cancer tumorigenesis still remains unclear. We utilized the Cancer Genome Atlas (TCGA) database to analyze comprehensive functions of in human breast cancer (BRCA) patients by investigating its expression patterns and methylation status in relation to clinical prognosis. expression was significantly diminished by hyper-methylation of the promoter region in specimens from BRCA patients compared to a healthy control group. Moreover, BRCA patients showed better prognosis and longer survival compared to BRCA patients. Consistent with clinical evidence, comparative transcriptome analysis combined with CRISPR/Cas9 or shRNA based perturbation of expression revealed direct as well as indirect mechanisms of that hinder tumorigenesis of BRCA cells. Taken together, our study enlightens a novel function of as a tumor suppressor in breast cancer cells.
在多种癌症中已显示出作为癌基因和肿瘤抑制基因的双重作用,但其在乳腺癌发生中的功能仍不清楚。我们利用癌症基因组图谱(TCGA)数据库,通过研究其在人类乳腺癌(BRCA)患者中的表达模式和甲基化状态与临床预后的关系,来分析其综合功能。与健康对照组相比,BRCA患者标本中该基因启动子区域的高甲基化显著降低了其表达。此外,该基因高表达的BRCA患者与低表达的BRCA患者相比,预后更好,生存期更长。与临床证据一致,比较转录组分析结合基于CRISPR/Cas9或shRNA的该基因表达干扰,揭示了该基因阻碍BRCA细胞肿瘤发生的直接和间接机制。综上所述,我们的研究揭示了该基因在乳腺癌细胞中作为肿瘤抑制因子的新功能。